Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/Valsartan in Dialysis Patients with Heart Failure
NCT04572724Phase 4Unknown
- Sponsor
- Shenzhen Second People's Hospital
- Start
- Jul 2020
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sacubitril + valsartan in heart failure (HF), sponsored by Shenzhen Second People's Hospital. Primary endpoint: Cardiovascular events at 18 months. Status: unknown.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04572724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04572724.